Sinovac Vaccine
- All
- News
-
China's Sinovac Covid Booster Weaker Against Omicron, Hong Kong Study Shows
Three doses of Sinovac's CoronaVac COVID-19 vaccine do not produce adequate levels of antibodies to fight the Omicron variant of the coronavirus, researchers from Hong Kong said in a statement.
-
Millions Took This Chinese Vaccine Against Covid. New Study Has Worrying Results.
The vaccine made by Sinovac Biotech Ltd., one of the most widely used in the world, doesn't provide sufficient antibodies to neutralize the omicron variant, said Hong Kong researchers in initial lab findings that may have sweeping consequences for th
-
UK To Recognise Covaxin, No Quarantine For Fully Vaccinated Travellers
Britain said it would recognise COVID-19 vaccines on the World Health Organization's Emergency Use Listing later this month, adding China's Sinovac, Sinopharm and India's Covaxin to the country's approved list of vaccines for inbound travellers.
-
Australia Recognises Covaxin For Travel As It Eases Border Curbs
Earlier, the Therapeutic Goods Administration (TGA) had recommended that only the vaccines approved for use in Australia, and Covishield from India and Sinovac from China be recognised for the purposes of travel and other restrictions.
-
Thailand To Stop Using Sinovac Covid Vaccine When Stocks End This Month
Thailand will stop using the COVID-19 vaccine of China's Sinovac when its current stock finishes, a senior official said, having used the shot extensively in combination with Western-developed vaccines.
-
WHO Experts Recommend 3rd Dose For Over-60s Jabbed With Sinopharm, Sinovac
The WHO's vaccine advisors recommended Monday that people over 60 who have been fully immunised with China's Sinovac and Sinopharm vaccine should be offered a third Covid-19 vaccine dose.
-
Covishield, China's Sinovac Approved By Australia Ahead Of Border Opening
Australia recognized China's Sinovac Biotech Ltd. COVID-19 shot and India-made AstraZeneca Plc jabs, paving the way for overseas travelers and fee-paying foreign students who have received those vaccinations to enter the country.
-
South Africa Vaccinates 2,000 Children In Trial Of Chinese Vaccine
South Africa on Friday joined the international Phase 3 clinical trials of China's Sinovac Biotech COVID-19 vaccine for those aged between 6 months and 17 years, with first of the 2,000 children receiving their jabs.
-
Sinovac Vaccine Antibody Levels May Decline In 6 Months, Booster Helps: Study
Antibodies triggered by Sinovac Biotech's COVID-19 vaccine declined below a key threshold from around six months after a second dose for most recipients, but a third shot had a strong booster effect, a lab study showed.
-
Thailand To Mix Sinovac, AstraZeneca Jabs "To Boost Protection Against Delta Variant"
Thailand's immunisation strategy against the coronavirus will see a shot of AstraZeneca's viral vector vaccine administered after one dose of Sinovac's vaccine, its health minister said on Monday.
-
China's Sinovac Covid Booster Weaker Against Omicron, Hong Kong Study Shows
Three doses of Sinovac's CoronaVac COVID-19 vaccine do not produce adequate levels of antibodies to fight the Omicron variant of the coronavirus, researchers from Hong Kong said in a statement.
-
Millions Took This Chinese Vaccine Against Covid. New Study Has Worrying Results.
The vaccine made by Sinovac Biotech Ltd., one of the most widely used in the world, doesn't provide sufficient antibodies to neutralize the omicron variant, said Hong Kong researchers in initial lab findings that may have sweeping consequences for th
-
UK To Recognise Covaxin, No Quarantine For Fully Vaccinated Travellers
Britain said it would recognise COVID-19 vaccines on the World Health Organization's Emergency Use Listing later this month, adding China's Sinovac, Sinopharm and India's Covaxin to the country's approved list of vaccines for inbound travellers.
-
Australia Recognises Covaxin For Travel As It Eases Border Curbs
Earlier, the Therapeutic Goods Administration (TGA) had recommended that only the vaccines approved for use in Australia, and Covishield from India and Sinovac from China be recognised for the purposes of travel and other restrictions.
-
Thailand To Stop Using Sinovac Covid Vaccine When Stocks End This Month
Thailand will stop using the COVID-19 vaccine of China's Sinovac when its current stock finishes, a senior official said, having used the shot extensively in combination with Western-developed vaccines.
-
WHO Experts Recommend 3rd Dose For Over-60s Jabbed With Sinopharm, Sinovac
The WHO's vaccine advisors recommended Monday that people over 60 who have been fully immunised with China's Sinovac and Sinopharm vaccine should be offered a third Covid-19 vaccine dose.
-
Covishield, China's Sinovac Approved By Australia Ahead Of Border Opening
Australia recognized China's Sinovac Biotech Ltd. COVID-19 shot and India-made AstraZeneca Plc jabs, paving the way for overseas travelers and fee-paying foreign students who have received those vaccinations to enter the country.
-
South Africa Vaccinates 2,000 Children In Trial Of Chinese Vaccine
South Africa on Friday joined the international Phase 3 clinical trials of China's Sinovac Biotech COVID-19 vaccine for those aged between 6 months and 17 years, with first of the 2,000 children receiving their jabs.
-
Sinovac Vaccine Antibody Levels May Decline In 6 Months, Booster Helps: Study
Antibodies triggered by Sinovac Biotech's COVID-19 vaccine declined below a key threshold from around six months after a second dose for most recipients, but a third shot had a strong booster effect, a lab study showed.
-
Thailand To Mix Sinovac, AstraZeneca Jabs "To Boost Protection Against Delta Variant"
Thailand's immunisation strategy against the coronavirus will see a shot of AstraZeneca's viral vector vaccine administered after one dose of Sinovac's vaccine, its health minister said on Monday.
